GLP-1 can increase insulin production in the pancreas and suppress appetite, resulting in improved tissue insulin sensitivity and weight loss, which is helpful in the treatment of obese patients with T2DM (15). The gene discussed is INS; the disease is type 2 diabetes mellitus.